CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 93 enrolled
Drug / intervention
Dual Energy CTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03404076
NCT03404076N/ACompleted
CompareCT.gov

Optimized Response Assessment of Gastrointestinal Stromal Tumors Using Dual-Energy CT: Prospective Multicenter-Multinational Trial in Patients Undergoing Targeted Therapy With a TKI Inhibitor.

Heidelberg University·observational·Posted Jan 19, 2018·Updated Apr 7, 2022

In Brief

An observational study evaluating Dual Energy CT for Gastrointestinal Stromal Tumor (GIST). Completed, enrolled 93 participants across 1 site.

Detailed Summary

The study investigates response assessment of gastrointestinal stromal tumors using Dual Energy CT (DECT) in patients undergoing targeted therapy with a TKI Inhibitor.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Stromal Tumor (GIST)
CountriesGermany
CollaboratorsInstitute of Clinical Radiology and Nuclear Medicine Mannheim, Siemens Healthcare Diagnostics Inc, Novartis Pharmaceuticals

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 19, 2018
Enrollment StartDec 1, 2014
Primary CompletionOct 31, 2020
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.9 yearsPosted 8.5 years ago

Interventions

Dual Energy CTother

Dual Energy CT is performed for diagnostic evaluation in gastrointestinal stromal tumor (GIST) patients undergoing tyrosine kinase inhibitor (TKI) treatment